“cystic-fibrosis” Archives

in
Entry Author Date Location
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug 05/30/17 San Diego
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
First Trial in Sight, Editas Cuts $90M Eye Drug Deal With Allergan 03/14/17 Boston
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3 12/28/16 San Francisco
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
Texas Roundup: Innovative Cities, Launches, & Deals, Deals, Deals! 06/21/16 Texas
Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates 06/21/16 Texas
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Tour of Texas: Savara, Brainspace, JLabs, InCube, Trinity University 03/07/16 Texas
Austin Biotech Savara Nets $20M in Series C for Phase 3 Study 03/01/16 Texas
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture 12/21/15 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Small Molecules: The Silent Majority of Pharmaceutical Pipelines 11/23/15 Boston
Page 1 of 6 next page »